Stability and treatment outcome of distinct classes of mania

European Psychiatry

Volumn 23, Issue 5, 2008, Pages 360-367

  van Rossum, Inge ^a   Haro, Josep Maria ^b   Tenback, Diederik ^c,d   Boomsma, Maarten ^e   Goetz, Iris ^f   Vieta, Eduard ^g   van Os, Jim ^h,i  

^a Eli Lilly Nederland   (Netherlands)

^b PARC SANITARI SANT JOAN DE DÉU   (Spain)

^c Symfora Group   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e GLAXOSMITHKLINE   (Netherlands)

^f ELI LILLY AND COMPANY   (United States)

^g UNIVERSITY OF BARCELONA   (Spain)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Mania and bipolar disorder; Psychiatry in Europe

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT;

ADULT; ALCOHOL ABUSE; ARTICLE; DISEASE CLASSIFICATION; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MONOTHERAPY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SOCIAL ADAPTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 47749097479     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.02.005     Document Type: Article

References (30)

1. APA practice guidelines for the treatment of patients with bipolar disorder (2002), American Psychiatric Association
2. Black D.W., Winokur G., Hulbert J., and Nasrallah A. Predictors of immediate response in the treatment of mania: the importance of comorbidity. Biol Psychiatry 24 (1988) 191-198
3. Brady K.T., and Sonne S.C. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56 (1995) 19-24
4. Cassidy F., Ahearn E.P., and Carroll B.J. Substance abuse in bipolar disorder. Bipolar Disord 3 (2001) 181-188
5. Cassidy F., Forest K., Murry E., and Carroll B.J. A factor analysis of the signs and symptoms of mania. Arch Gen Psychiatry 55 (1998) 27-32
6. Dilsaver S.C., Chen Y.R., Shoaib A.M., and Swann A.C. Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry 156 3 (1999) 426-430
7. Feinman J.A., and Dunner D.L. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 37 (1996) 43-49
8. Feske U., Frank E., Mallinger A.G., Houck P.R., Fagiolini A., Shear M.K., et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry 157 (2000) 956-962
9. Fountoukalis K.N., Vieta E., Sanchez-Morena J., Kaprinis S.G., Goikolea J.M., and Kaprinis G.S. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86 (2005) 1-10
10. Goetz I., Tohen M., Reed C., Lorenzo M., Vieta E., and the EMBLEM Advisory Board. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 9 1-2 (2007) 45-52
11. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., and Portera L. Association of recurrent suicidal ideation with nonremission from acute mixed mania. Am J Psychiatry 155 (1998) 1753-1755
12. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., and Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 60 (1999) 733-740
13. Goldstein H. Multilevel models in educational and social research (1987), Griffin, London
14. Gonzalez-Pinto A., Ballesteros J., Aldama A., Pérez de Heredia J.L., Gutierrez M., Mosquera F., et al. Principal components of mania. J Affect Disord 76 (2003) 95-102
15. Haro J.M., van Os J., Vieta E., Reed C., Lorenzo M., Goetz I., et al. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand 113 (2006) 112-120
16. Kessing L.V. Subtypes of manic episodes according to ICD-10: prediction of time to remission and risk of relapse. J Affect Disord 81 (2004) 279-285
17. Kraepelin E. Manic-depressive insanity and paranoia. [Barclay RM, Trans.]. In: Robertson G.M. (Ed) (1976), Arno Press, New York
18. Licht R.W., Gouliaev G., Vestergard P., and Frydenberg M. Generalisability of results from randomised drug trials: a trial on antimanic treatment. Br J Psychiatry 170 (1997) 264-267
19. Mant J., Dawes M., and Graham-Jones S. Internal validity of trials is more important than generalisibility. Br J Med 312 (1996) 779
20. van Os J., van Rossum I., Boomsma M., Vieta E., Goetz I., Reed C., et al. The social, psychopathological and consumer context of rate of symptom improvement in acute mania. Soc Psychiatry Psychiatr Epidemiol 42 8 (2007) 631-638
21. Sato T., Bottlender R., Kleindienst N., and Moller H.J. Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry 159 (2002) 968-974
22. Spearing M.K., Post R.M., and Leverich G.S. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73 (1997) 159-171
23. STATACORP. Stata statistical software: release 9.1 (2005), Stata Corporation, College Station, TX
24. Vieta E., and Carne X. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom 74 (2005) 10-16
25. Welge J.A., Keck P.E., and Meinhold J.M. Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials. J Clin Psychopharmacol 24 (2004) 607-612
26. Wells K.B. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 156 (1999) 5-10
27. Wilkins J.N., Shaner A.L., Patterson C.M., Setoda D., and Gorelick D. Discrepancies between patient report, clinical assessment and urine analysis in psychiatric patients during inpatient admission. Psychopharmacol Bull 27 (1991) 149-154
28. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
29. Zarate C.A., Narendran R., Tohen M., Greaney J.J., Berman A., Pike S., et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 59 (1998) 24-28
30. Zarate C.A., Rothschild A., Fletcher K.E., Madrid A., and Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 61 (2000) 185-189